Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Shively

Showing results (341-350 of 458) with videos related to

Pageof 46
Sort By:
Cancer Medicine|February 6, 2024
Comparison of IL-2-antibody to IL-2-Fc with or without stereotactic radiation therapy in CEA immunocompetent mice with CEA positive tumorsLindsay Williams, Lin Li, Paul J Yazaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1984
Generation of antibody activity from immunoglobulin polypeptide chains produced in Escherichia coliS Cabilly, A D Riggs, H Pande, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 17, 2010
A pretherapy biodistribution and dosimetry study of indium-111-radiolabeled trastuzumab in patients with human epidermal growth factor receptor 2-overexpressing breast cancerJeffrey Y C Wong, Andrew Raubitschek, Dave Yamauchi, et al.
Biotechnology Journal|June 10, 2023
Generation of IL-2-Fc-antibody conjugates by click chemistryLindsay Williams, Lin Li, Paul J Yazaki, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 14, 2025
Combination Image-Guided and Antibody-Targeted α-Therapy Before Targeted Immunotherapy for Treatment of Solid TumorsMaciej Kujawski, Eric Aniogo, Patty Wong, et al.
The Journal of Trauma|March 1, 1997
Impact of level III verification on trauma admissions and transfer: comparisons of two rural hospitalsJ D Richardson, T Cross, D Lee, et al.
Journal of Immunological Methods|June 1, 2001
Mammalian expression and hollow fiber bioreactor production of recombinant anti-CEA diabody and minibody for clinical applicationsP J Yazaki, L Shively, C Clark, et al.
The Journal of Biological Chemistry|July 5, 1991
Purification and structural characterization of progastrin-derived peptides from a human gastrinomaV D Huebner, R L Jiang, T D Lee, et al.
Bioconjugate Chemistry|April 21, 2001
Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragmentsP J Yazaki, A M Wu, S W Tsai, et al.
Mbio|February 6, 2020
The HopQ-CEACAM Interaction Controls CagA Translocation, Phosphorylation, and Phagocytosis of <i>Helicobacter pylori</i> in NeutrophilsIna-Kristin Behrens, Benjamin Busch, Hellen Ishikawa-Ankerhold, et al.
Pageof 46

Showing results (341-350 of 458) with videos related to

Sort By:
Pageof 46
Cancer Medicine|February 6, 2024
Comparison of IL-2-antibody to IL-2-Fc with or without stereotactic radiation therapy in CEA immunocompetent mice with CEA positive tumorsLindsay Williams, Lin Li, Paul J Yazaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1984
Generation of antibody activity from immunoglobulin polypeptide chains produced in Escherichia coliS Cabilly, A D Riggs, H Pande, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 17, 2010
A pretherapy biodistribution and dosimetry study of indium-111-radiolabeled trastuzumab in patients with human epidermal growth factor receptor 2-overexpressing breast cancerJeffrey Y C Wong, Andrew Raubitschek, Dave Yamauchi, et al.
Biotechnology Journal|June 10, 2023
Generation of IL-2-Fc-antibody conjugates by click chemistryLindsay Williams, Lin Li, Paul J Yazaki, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 14, 2025
Combination Image-Guided and Antibody-Targeted α-Therapy Before Targeted Immunotherapy for Treatment of Solid TumorsMaciej Kujawski, Eric Aniogo, Patty Wong, et al.
The Journal of Trauma|March 1, 1997
Impact of level III verification on trauma admissions and transfer: comparisons of two rural hospitalsJ D Richardson, T Cross, D Lee, et al.
Journal of Immunological Methods|June 1, 2001
Mammalian expression and hollow fiber bioreactor production of recombinant anti-CEA diabody and minibody for clinical applicationsP J Yazaki, L Shively, C Clark, et al.
The Journal of Biological Chemistry|July 5, 1991
Purification and structural characterization of progastrin-derived peptides from a human gastrinomaV D Huebner, R L Jiang, T D Lee, et al.
Bioconjugate Chemistry|April 21, 2001
Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragmentsP J Yazaki, A M Wu, S W Tsai, et al.
Mbio|February 6, 2020
The HopQ-CEACAM Interaction Controls CagA Translocation, Phosphorylation, and Phagocytosis of <i>Helicobacter pylori</i> in NeutrophilsIna-Kristin Behrens, Benjamin Busch, Hellen Ishikawa-Ankerhold, et al.
Pageof 46